TY - JOUR
T1 - Residential Treatment Exclusively for Tobacco Use Disorder
T2 - A Narrative Review
AU - Spoelstra, Symen Kornelis
AU - van de Graaf, Robert C.
AU - Dijkstra, Arie
N1 - Publisher Copyright:
Copyright © 2023 American Society of Addiction Medicine.
PY - 2024/1/1
Y1 - 2024/1/1
N2 - Introduction: Tobacco use disorder is a major public health issue, and novel smoking cessation approaches are urgently needed. Residential treatment programs have been suggested as a potentially effective treatment for tobacco use disorder. However, there is limited literature on residential treatment programs for patients who are exclusively dependent on nicotine. Aim: The aim of this study is to review the literature on residential treatment programs for patients admitted exclusively for tobacco use disorder. Methods: A literature search was conducted in PubMed with the aim of identifying relevant articles on residential treatment exclusively for tobacco use disorder from inception until February 2023. References in retrieved articles were screened for additional relevant articles. Results: Fourteen studies on residential treatment programs for tobacco use disorder were identified. The duration of the residential cessation programs ranged from 3 days to 3 weeks. Individualized or group cognitive behavioral therapy and tailored pharmacotherapy were the key components of the programs. Eligibility criteria for the programs included moderate to severe tobacco use disorder as measured by Fagerström or Diagnostic and Statistical Manual of Mental Disorders (DSM), consistent relapses, smoking-related comorbidities (eg, cardiovascular or pulmonary diseases), and daily use of (smokeless) tobacco. The 6- and 12-month 7-day point prevalence rate ranged from 58% to 26%, whereas the 6- and 12-month continuous abstinence rate ranged from 52% to 29%. Conclusions: Based on the literature we reviewed, residential smoking cessation programs targeted exclusively at individuals with tobacco use disorder have shown effectiveness, particularly for those who are highly dependent on tobacco and have a history of relapse. However, more research is needed to further explore the effectiveness of these programs and to determine the optimal program components and duration.
AB - Introduction: Tobacco use disorder is a major public health issue, and novel smoking cessation approaches are urgently needed. Residential treatment programs have been suggested as a potentially effective treatment for tobacco use disorder. However, there is limited literature on residential treatment programs for patients who are exclusively dependent on nicotine. Aim: The aim of this study is to review the literature on residential treatment programs for patients admitted exclusively for tobacco use disorder. Methods: A literature search was conducted in PubMed with the aim of identifying relevant articles on residential treatment exclusively for tobacco use disorder from inception until February 2023. References in retrieved articles were screened for additional relevant articles. Results: Fourteen studies on residential treatment programs for tobacco use disorder were identified. The duration of the residential cessation programs ranged from 3 days to 3 weeks. Individualized or group cognitive behavioral therapy and tailored pharmacotherapy were the key components of the programs. Eligibility criteria for the programs included moderate to severe tobacco use disorder as measured by Fagerström or Diagnostic and Statistical Manual of Mental Disorders (DSM), consistent relapses, smoking-related comorbidities (eg, cardiovascular or pulmonary diseases), and daily use of (smokeless) tobacco. The 6- and 12-month 7-day point prevalence rate ranged from 58% to 26%, whereas the 6- and 12-month continuous abstinence rate ranged from 52% to 29%. Conclusions: Based on the literature we reviewed, residential smoking cessation programs targeted exclusively at individuals with tobacco use disorder have shown effectiveness, particularly for those who are highly dependent on tobacco and have a history of relapse. However, more research is needed to further explore the effectiveness of these programs and to determine the optimal program components and duration.
KW - addiction
KW - nicotine dependence
KW - residential treatment
KW - smoking cessation
KW - tobacco use disorder
UR - http://www.scopus.com/inward/record.url?scp=85184292639&partnerID=8YFLogxK
U2 - 10.1097/ADM.0000000000001234
DO - 10.1097/ADM.0000000000001234
M3 - Article
C2 - 37847568
AN - SCOPUS:85184292639
SN - 1932-0620
VL - 18
SP - 33
EP - 41
JO - Journal of Addiction Medicine
JF - Journal of Addiction Medicine
IS - 1
ER -